Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicoletta Pingelli"'
Autor:
Federico Sanchez, Valentina Boasi, Matteo Vercellino, Chiara Tacchi, Pierpaolo Cannarile, Nicoletta Pingelli, Dino Perri, Laura Gomez, Stefano Cattunar, Giovanni Mascelli
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The PEGASUS-TIMI 54 trial inclusion criteria effectively identified high-risk patients with recent myocardial infarction (MI) who would benefit from continuing dual antiplatelet therapy (DAPT) with ticagrelor for more than 12 mont
Externí odkaz:
https://doaj.org/article/f58c70d9ba7a49aca6ed1db97016af2a
Autor:
Nicola Forni, Valentina Boasi, Katiuscia Sciole, Silvia Borile, Nicoletta Pingelli, Domenico Marra, Sara Tita Farinella, Giovanni Cenderello, Federico Ariel Sanchez
Publikováno v:
Geriatric Care, Vol 6, Iss 3 (2020)
The recent outbreak exposed doctors to a new challenge: treating people without any scientific evidence. All molecules combined in treatment schedules were merged on the basis of weak and anecdotal data so, the recommendations are constantly changing
Externí odkaz:
https://doaj.org/article/cbabd2521cc345c18a21b81d36f87f62
Autor:
Giovanni Mascelli, Stefano Cattunar, Pierpaolo Cannarile, Nicoletta Pingelli, Federico Ariel Sanchez, Laura Gomez, Chiara Tacchi, Dino Perri, Valentina Boasi, Matteo Vercellino
Publikováno v:
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Background The PEGASUS-TIMI 54 trial inclusion criteria effectively identified high-risk patients with recent myocardial infarction (MI) who would benefit from continuing dual antiplatelet therapy (DAPT) with ticagrelor for more than 12 months. It is
Autor:
Valentina Boasi, Katiuscia Sciole, Giovanni Cenderello, Federico Ariel Sanchez, Silvia Borile, Domenico Marra, Sara Tita Farinella, Nicola Forni, Nicoletta Pingelli
Publikováno v:
Geriatric Care, Vol 6, Iss 3 (2020)
The recent outbreak exposed doctors to a new challenge: treating people without any scientific evidence. All molecules combined in treatment schedules were merged on the basis of weak and anecdotal data so, the recommendations are constantly changing